×
For best experience we recommend to activate Javascript in your browser.
OCIAD2 antibody (AA 1-154)
This Rabbit Polyclonal antibody specifically detects OCIAD2 in WB, IHC, IP and ICC. It exhibits reactivity toward Human.
Quick Overview for OCIAD2 antibody (AA 1-154) (ABIN7624048)
Target
See all OCIAD2 Antibodies
OCIAD2
(OCIA Domain Containing 2 (OCIAD2))
Reactivity
All reactivities for OCIAD2 antibodies
Human
Host
All hosts for OCIAD2 antibodies
Rabbit
Clonality
All clonalities for OCIAD2 antibodies
Polyclonal
Conjugate
All conjugates for OCIAD2 antibodies
This OCIAD2 antibody is un-conjugated
Application
All applications for OCIAD2 antibodies
Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)
Product Details anti-OCIAD2 Antibody
(hide)
Binding Specificity
All epitopes for OCIAD2 antibodies
AA 1-154
Purpose
Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2) Polyclonal Antibody
Sequence
Met1~Ser154
Characteristics
The Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2) Polyclonal Antibody (Species: Human) has been validated for the following applications: WB, IHC, ICC, IP.
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
0.41 mg/mL
Buffer
PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
Expiry Date
12 months
Target Details for OCIAD2
(hide)
Target
OCIAD2
(OCIA Domain Containing 2 (OCIAD2))
Alternative Name
OCIAD2
Gene ID
132299
UniProt
Q56VL3
Recently viewed
(hide)
Chat with us , powered by LiveChat